InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Pfeffer Cary, Director. Insider active across 1 company, notably Jounce Therapeutics, Inc.. Aggregated, 6 reports have been logged. Split: 0 buy · 2 sells. Activity tracked since 12 November 2021. The latest transaction was disclosed on 12 November 2021 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
00Common StockSEC:0000899243-21-044914
00Common StockSEC:0000899243-21-044914:0
0Common StockSEC:0000899243-21-036399
0Common StockSEC:0000899243-21-036399:0
0Common StockSEC:0000899243-21-023559
0Common StockSEC:0000899243-21-023559:0
6 of 6 declarations
About Pfeffer Cary
Cary Pfeffer is a Board Member at Jounce Therapeutics, Inc. He brings expertise in biotechnology and product development. His role involves guiding the company's direction and ensuring that strategic decisions align with growth objectives.
